GB0021520D0 - Treatment of neuropathy - Google Patents

Treatment of neuropathy

Info

Publication number
GB0021520D0
GB0021520D0 GB0021520A GB0021520A GB0021520D0 GB 0021520 D0 GB0021520 D0 GB 0021520D0 GB 0021520 A GB0021520 A GB 0021520A GB 0021520 A GB0021520 A GB 0021520A GB 0021520 D0 GB0021520 D0 GB 0021520D0
Authority
GB
United Kingdom
Prior art keywords
neuropathy
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0021520A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0021520A priority Critical patent/GB0021520D0/en
Priority to IL152925A priority patent/IL152925A/en
Priority to IL13907300A priority patent/IL139073A0/en
Priority to EP04010436A priority patent/EP1440709B1/en
Priority to EP00309129A priority patent/EP1129706A3/en
Priority to ES04010436T priority patent/ES2295726T3/en
Priority to AT04010436T priority patent/ATE380049T1/en
Priority to DE60037347T priority patent/DE60037347T2/en
Priority to PT04010436T priority patent/PT1440709E/en
Priority to TW91124370A priority patent/TWI299989B/en
Priority to DK04010436T priority patent/DK1440709T3/en
Publication of GB0021520D0 publication Critical patent/GB0021520D0/en
Priority to ZA200005825A priority patent/ZA200005825B/en
Priority to CA002323839A priority patent/CA2323839C/en
Priority to CO00080163A priority patent/CO5271711A1/en
Priority to AU66650/00A priority patent/AU781550B2/en
Priority to HU0004120A priority patent/HUP0004120A3/en
Priority to PE2000001133A priority patent/PE20010754A1/en
Priority to KR1020000062129A priority patent/KR20010051181A/en
Priority to JP2000322510A priority patent/JP2001122803A/en
Priority to US10/206,615 priority patent/US20030162782A1/en
Priority to JP2002297617A priority patent/JP2003119131A/en
Priority to IL15292502A priority patent/IL152925A0/en
Priority to US10/731,905 priority patent/US20040122010A1/en
Priority to CY20081100193T priority patent/CY1107285T1/en
Ceased legal-status Critical Current

Links

GB0021520A 1999-10-21 2000-09-01 Treatment of neuropathy Ceased GB0021520D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0021520A GB0021520D0 (en) 2000-09-01 2000-09-01 Treatment of neuropathy
IL152925A IL152925A (en) 1999-10-21 2000-10-16 Pharmaceutical compositions for treatment of neuropathy comprising an inhibitor of cyclic guanosine 3',5'-monophosphate phosphodiesterase 5 and either gabapentin or pregabalin
IL13907300A IL139073A0 (en) 1999-10-21 2000-10-16 Treatment of neuropathy
DK04010436T DK1440709T3 (en) 1999-10-21 2000-10-17 Combinations comprising cGMP PDE5 inhibitors
EP00309129A EP1129706A3 (en) 1999-10-21 2000-10-17 Use of cGMP PDE5 inhibitors for the treatment of neuropathy
EP04010436A EP1440709B1 (en) 1999-10-21 2000-10-17 Combinations comprising cGMP PDE5 inhibitors.
ES04010436T ES2295726T3 (en) 1999-10-21 2000-10-17 COMBINATIONS THAT INCLUDE CMP CPDE5 INHIBITORS.
AT04010436T ATE380049T1 (en) 1999-10-21 2000-10-17 COMBINATIONS CONTAINING CGMP-PDE5 INHIBITORS.
DE60037347T DE60037347T2 (en) 1999-10-21 2000-10-17 Combinations containing cGMP-PDE5 inhibitor.
PT04010436T PT1440709E (en) 1999-10-21 2000-10-17 Combinations comprising cgmp pde5 inhibitors.
TW91124370A TWI299989B (en) 2000-09-01 2000-10-17 Treatment of neuropathy
ZA200005825A ZA200005825B (en) 2000-09-01 2000-10-19 Treatment of neuropathy.
CA002323839A CA2323839C (en) 1999-10-21 2000-10-19 Treatment of neuropathy
PE2000001133A PE20010754A1 (en) 1999-10-21 2000-10-20 USE OF 3 ', 5'-CYCLIC GUANOSIMMONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHY
CO00080163A CO5271711A1 (en) 1999-10-21 2000-10-20 A COMPOSITION THAT INCLUDES SILDENAFIL OR 3-ETIL-5- [5- (4-ETIL-PIPERAZINA-1-SULFONIL) -2-PROPOXI-PHENYL] -2-PIRIDINH-2-ILMETIL-2.6-DIHYDROPIRAZOL [4,3- D] PIRIMIDIN-7-ONA AND GABAPENTINA OR PREGABALINE FOR THE TREATMENT OF DIABETIC NEUROPATHY
AU66650/00A AU781550B2 (en) 1999-10-21 2000-10-20 Treatment of neuropathy
HU0004120A HUP0004120A3 (en) 1999-10-21 2000-10-20 Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
KR1020000062129A KR20010051181A (en) 1999-10-21 2000-10-21 Treatment of neuropathy
JP2000322510A JP2001122803A (en) 1999-10-21 2000-10-23 Treatment of neuropathy
US10/206,615 US20030162782A1 (en) 1999-10-21 2002-07-26 Treatment of neuropathy
JP2002297617A JP2003119131A (en) 1999-10-21 2002-10-10 Treatment of neuropathy
IL15292502A IL152925A0 (en) 1999-10-21 2002-11-18 Treatment of neuropathy
US10/731,905 US20040122010A1 (en) 1999-10-21 2003-12-10 Treatment of neuropathy
CY20081100193T CY1107285T1 (en) 1999-10-21 2008-02-18 CGMP PDE5 Inhibitors Combined

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0021520A GB0021520D0 (en) 2000-09-01 2000-09-01 Treatment of neuropathy

Publications (1)

Publication Number Publication Date
GB0021520D0 true GB0021520D0 (en) 2000-10-18

Family

ID=9898687

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0021520A Ceased GB0021520D0 (en) 1999-10-21 2000-09-01 Treatment of neuropathy

Country Status (3)

Country Link
GB (1) GB0021520D0 (en)
TW (1) TWI299989B (en)
ZA (1) ZA200005825B (en)

Also Published As

Publication number Publication date
TWI299989B (en) 2008-08-21
ZA200005825B (en) 2002-04-19

Similar Documents

Publication Publication Date Title
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
GB0014969D0 (en) Novel method of treatment
AU5464601A (en) Treatment of scale
EG25829A (en) Novel treatment
PL362855A1 (en) Improved treatment
GB0030845D0 (en) Novel treatment
GB0011186D0 (en) Modification of bacteria
TW444674U (en) Improved structure of ornament
HUP0301725A3 (en) Novel compounds and process
AU9402401A (en) Treatment of cancers
GB0008921D0 (en) Method of treatment
GB0014356D0 (en) Treatment of multiple sclerosis
IL161630A0 (en) Methods of treating endometreosis
GB0103031D0 (en) Novel treatment
EP1303281A4 (en) Methods of treatment
GB0029125D0 (en) Novel treatment
GB0031321D0 (en) Treatment
GB0021520D0 (en) Treatment of neuropathy
GB0019728D0 (en) Novel treatment
GB9924958D0 (en) Treatment of neuropathy
IL152925A0 (en) Treatment of neuropathy
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
GB0029122D0 (en) Novel treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)